E2F1 and cancer: We validated these findings using publicly available scRNAseq data [50] and found that cancer cells expressing Ki-67 and E2F1 overlapped and the percentage of cancer cells expressing Ki-67 varied among the 23 patients and correlated with the percentage of cancer cells expressing E2F1 (Fig. 3i).